Sight Sciences Stock Beta
| SGHT Stock | USD 3.58 0.14 3.76% |
Sight Sciences fundamentals help investors to digest information that contributes to Sight Sciences' financial success or failures. It also enables traders to predict the movement of Sight Stock. The fundamental analysis module provides a way to measure Sight Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sight Sciences stock.
Sight | Beta |
Sight Sciences Company Beta Analysis
Sight Sciences' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Sight Sciences Beta | 2.73 |
Most of Sight Sciences' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sight Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Sight Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Sight Sciences is extremely important. It helps to project a fair market value of Sight Stock properly, considering its historical fundamentals such as Beta. Since Sight Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sight Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sight Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Sight Sciences has a Beta of 2.734. This is 217.91% higher than that of the Health Care Equipment & Supplies sector and 162.88% higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Sight Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sight Sciences' direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sight Sciences could also be used in its relative valuation, which is a method of valuing Sight Sciences by comparing valuation metrics of similar companies.Sight Sciences is currently under evaluation in beta category among its peers.
Sight Sciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sight Sciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sight Sciences' managers, analysts, and investors.Environmental | Governance | Social |
Sight Sciences Institutional Holders
Institutional Holdings refers to the ownership stake in Sight Sciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sight Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sight Sciences' value.| Shares | Northern Trust Corp | 2024-09-30 | 325.8 K | D. E. Shaw & Co Lp | 2024-09-30 | 321.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 257 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 223.9 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 207.9 K | Panagora Asset Management Inc | 2024-09-30 | 194.8 K | National Asset Management Inc | 2024-06-30 | 185.1 K | Millrace Asset Group, Inc | 2024-09-30 | 138.8 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 136 K | Ubs Group Ag | 2024-09-30 | 2.5 M | Blackrock Inc | 2024-06-30 | 2.1 M |
As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sight Sciences will likely underperform.
Sight Fundamentals
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.63) % | ||||
| Operating Margin | (0.56) % | ||||
| Current Valuation | 97.15 M | ||||
| Shares Outstanding | 50.4 M | ||||
| Shares Owned By Insiders | 20.43 % | ||||
| Shares Owned By Institutions | 51.10 % | ||||
| Number Of Shares Shorted | 984.57 K | ||||
| Price To Book | 1.90 X | ||||
| Price To Sales | 2.27 X | ||||
| Revenue | 81.06 M | ||||
| Gross Profit | 58.97 M | ||||
| EBITDA | (49.41 M) | ||||
| Net Income | (55.55 M) | ||||
| Cash And Equivalents | 220.1 M | ||||
| Cash Per Share | 4.60 X | ||||
| Total Debt | 35.41 M | ||||
| Debt To Equity | 0.18 % | ||||
| Current Ratio | 16.73 X | ||||
| Book Value Per Share | 1.88 X | ||||
| Cash Flow From Operations | (47.18 M) | ||||
| Short Ratio | 3.66 X | ||||
| Earnings Per Share | (1.01) X | ||||
| Target Price | 5.02 | ||||
| Number Of Employees | 214 | ||||
| Beta | 2.73 | ||||
| Market Capitalization | 180.43 M | ||||
| Total Asset | 166.65 M | ||||
| Retained Earnings | (294.79 M) | ||||
| Working Capital | 150.62 M | ||||
| Net Asset | 166.65 M |
About Sight Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sight Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sight Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sight Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sight Stock Analysis
When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.